Clinical Trials Logo
  1. Home
  2. Fibroids
  3. NCT02620345

Fibroids in Women of Reproductive Age and Women Pregnancy — Fibroids  

Fibroids Clinical Trial

Official title:
Uterine Fibroids Are a Very Common Finding in Women of Reproductive Age. Ready Safety Study Dydrogesterone + Multivitamin Nature in Women of Reproductive Age and Women Pregnancy

Clinical Trial Summary

Dydrogesterone Multivitamin Nature treatment of fibroids in women of reproductive age and women pregnancy to lost the size fibroids.

Clinical Trial Description

Uterine fibroids are a very common finding in women of reproductive age. But may fibroids grow in the first trimester pregnancy.

Clinically has shown that:

Uterine fibroids are associated with an Heavy or prolonged menstrual periods. Abnormal bleeding between menstrual periods.

Uterine fibroids are associated with an increased rate of spontaneous miscarriage, preterm labor, placenta abruption, malpresentation, labor dystocia, cesarean delivery, and postpartum hemorrhage, pain is the most common complication of fibroids during pregnancy. Can usually be controlled by conservative treatment on Dydrogesterone Multivitamin nature. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02620345
Study type Interventional
Source Triê?u, Nguyê~n Thi?, M.D.
Contact
Status Completed
Phase Phase 4
Start date January 2010
Completion date November 2015
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Terminated NCT02209545 - Misoprostol for Reduction of Blood Loss During Fibroid Surgery Phase 4
Completed NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Phase 2
Recruiting NCT04849858 - Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures Phase 3
Terminated NCT00001850 - Evaluation of Women With Endocrine and Reproductive-Related Conditions
Completed NCT02620748 - Use of Intravenous Tranexamic Acid During Myomectomy Phase 1
Completed NCT02954744 - High-intensity Focused Ultrasound in Treatment of Uterine Fibroid N/A
Terminated NCT00710346 - Establishment of Fibroid Tissue Bank
Withdrawn NCT02703246 - Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes N/A
Not yet recruiting NCT01347385 - Barbed Suture Versus Traditional Suture Material for Laparoscopic Myomectomy N/A
Completed NCT01581944 - Gonadotropin-releasing Hormone Agonist Prior to Myomectomy Phase 3
Completed NCT04071574 - Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Phase 1/Phase 2
Completed NCT02812186 - Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Phase 4
Recruiting NCT02288130 - Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy Phase 4
Completed NCT04550429 - Uterine Filling Pressure in Hysteroscopy N/A
Withdrawn NCT01671215 - Endometrial and Myometrial Changes, With and Without Fibroids N/A
Completed NCT01936493 - Biologic Predictors of Leiomyoma Treatment Outcomes N/A
Completed NCT00995878 - The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. Phase 4